Sequential Use of Second-Generation Tyrosine Kinase Inhibitor Treatment and Intensive Chemotherapy Induced Long-Term Complete Molecular Response in Imatinib-Resistant CML Patient Presenting as a Myeloid Blast Crisis

Myeloid blast crisis of chronic myeloid leukemia (CML-MBC) is rarely seen at presentation and has a poor prognosis. There is no standard therapy for CML-MBC. It is often difficult to distinguish CML-MBC from acute myeloid leukemia expressing the Philadelphia chromosome (Ph+ AML). We present a case i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuji, Masaaki, Uchiyama, Tatsuki, Mizumoto, Chisaki, Takeoka, Tomoharu, Tomo, Kenjiro, Ohno, Tatsuharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748101/
https://www.ncbi.nlm.nih.gov/pubmed/29391957
http://dx.doi.org/10.1155/2017/3209305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748101/
https://www.ncbi.nlm.nih.gov/pubmed/29391957
http://dx.doi.org/10.1155/2017/3209305

Ejemplares similares